.png)
CHILDHOOD CANCER SURVIVORSHIP CARE OVERVIEW
7 Jan 2022
20:00-21:30 (UTC +8 | Singapore Time)
06.00-07.30 (UTC -6 | Memphis Time)
Melissa M. Hudson
St. Jude's Children Research Hospital
Lecture #1: Introduction to Late Effects
By the end of the session, attendees will be able to:
-
Appreciate how childhood cancer treatment affects long-term health
-
Understand the spectrum of late effects of childhood cancer
-
Understand the concept of risk-based survivorship care
​​
Matthew Ehrhardt
St. Jude's Children Research Hospital
Lecture #2: Survivorship Care Planning
By the end of the session, attendees will be able to:
-
Understand the historical context for the development of the survivorship care plan tool
-
Describe the content and purpose of a survivorship care plan
-
Describe models of survivorship care
-
Identify resources to guide survivorship care
ORGAN HEALTH AFTER CHILDHOOD CANCER
PART 1
21 Jan 2022
20:00-21:30 (UTC +8 | Singapore Time)
06.00-07.30 (UTC -6 | Memphis Time)
Daniel Mulrooney
St. Jude's Children Research Hospital
Lecture #1: Cardiac Late Effects
​
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of cardiac late effects in childhood cancer survivors
-
Identify risk factors for cardiac late effects
-
Understand recommended screening for cardiac late effects
-
Describe the impact of modifiable risk factors on risk of cardiac late effects
​
Neel Bhatt
Fred Hutchinson Cancer Center
Lecture #2: Pulmonary Late Effects
​
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of pulmonary late effects in childhood cancer survivors
-
Identify risk factors for pulmonary late effects
-
Understand recommended screening for pulmonary late effects
-
Describe the impact of modifiable risk factors on risk of pulmonary late effects
ORGAN HEALTH AFTER CHILDHOOD CANCER
PART 2
11 Feb 2022
20:00-21:30 (UTC +8 | Singapore Time)
06.00-07.30 (UTC -6 | Memphis Time)
Wassim Chemaitilly
St. Jude's Children Research Hospital
Lecture #1: Endocrine Late Effects – Hypothalamic-Pituitary Axis
​
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of hypothalamic-pituitary axis late effects in childhood cancer survivors
-
Identify risk factors for hypothalamic-pituitary axis late effects
-
Understand recommended screening for hypothalamic-pituitary axis late effect
Stephanie Dixon
St. Jude's Children Research Hospital
Lecture #2: Metabolic Late Effects – Obesity, Insulin Resistance
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of metabolic late effects in childhood cancer survivors
-
Identify risk factors for metabolic late effects
-
Understand recommended screening for metabolic late effects
ORGAN HEALTH AFTER CHILDHOOD CANCER
PART 3
25 Feb 2022
20:00-21:30 (UTC +8 | Singapore Time)
06.00-07.30 (UTC -6 | Memphis Time)
Rod Skinner
Great North Children's Hospital
Lecture #1: Renal and Bladder Late Effects
​
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of renal and bladder late effects in childhood cancer survivors
-
Identify risk factors for renal and bladder late effects
-
Understand recommended screening for renal and bladder late effects
-
Describe the impact of modifiable risk factors on risk of renal and bladder late effects
​​
Sharon Castellino
Children’s Healthcare of Atlanta
Lecture #2: Hepatic Late Effects
​
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of hepatic late effects in childhood cancer survivors
-
Identify risk factors for hepatic late effects
-
Understand recommended screening for hepatic late effects
-
Describe the impact of modifiable risk factors on risk of hepatic late effects
PSYCHOSOCIAL & NEUROCOGNITIVE LATE EFFECTS OF CHILDHOOD CANCER
12 March 2022
20:00-21:30 (UTC +8 | Singapore Time)
06.00-07.30 (UTC -6 | Memphis Time)
Yin Ting Cheung
Chinese University of Hong Kong
Kevin Krull
St. Jude's Children Research Hospital
Fiona Schulte
University of Calgary
Lecture #1: Neurocognitive Late Effects After Childhood Cancer
​
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of neurocognitive late effects in childhood cancer survivors
-
Identify risk factors for neurocognitive late effects
-
Understand recommended screening for neurocognitive late effects
Lecture #2: Interventions for Neurocognitive Late Effects
​
By the end of the session, attendees will be able to:
-
Describe interventions to prevent/remediate neurocognitive deficits in children and adolescents
-
Describe interventions for healthy brain aging in adults treated for childhood cancer
Lecture #3: Psychosocial Outcomes After Childhood Cancer
By the end of the session, attendees will be able to:
-
Describe psychosocial outcomes in childhood cancer survivors
-
Identify risk factors for deficits in psychosocial outcomes
-
Understand recommended screening and interventions to optimize psychosocial outcomes
ORGAN HEALTH AFTER CHILDHOOD CANCER
PART 4
25 March 2022
20:00-21:30 (UTC +8 | Singapore Time)
07.00-08.30 (UTC -6 | Memphis Time)
Sogol Mostoufi-Moab
Children's Hospital of Philadelphia
Lecture #1: Late Effects on Bone Health: Bone Mineral Density
​
By the end of the session, attendees will be able to:
-
Describe the prevalence of bone mineral density deficits in childhood cancer survivors
-
Identify risk factors for osteopenia/osteoporosis
-
Understand recommended screening for bone mineral density deficits
​
Seth Karol
St. Jude's Children Research Hospital
Lecture #2: Late Effects on Bone Health – Osteonecrosis
By the end of the session, attendees will be able to:
-
Describe the prevalence of osteonecrosis in childhood cancer survivors
-
Identify risk factors for osteonecrosis
-
Understand recommended screening for osteonecrosis
REPRODUCTIVE LATE EFFECTS AND PREGNANCY OUTCOMES
8 April 2022
20:00-21:30 (UTC +8 | Singapore Time)
07.00-08.30 (UTC -6 | Memphis Time)
Jennifer Levine
Weill Cornell Medicine
Lecture #1: Reproductive Late Effects in Female Cancer Survivors
​
By the end of the session, trainees will be able to:
-
Describe the prevalence and type of reproductive late effects female childhood cancer survivors
-
Identify risk factors of infertility and adverse pregnancy outcomes
-
Understand recommended screening for reproductive late effects
-
Appreciate options for fertility preservation
Daniel Green
St. Jude's Children Research Hospital
Lecture #2: Reproductive Late Effects in Male Cancer Survivors
​
By the end of the session, trainees will be able to:
-
Describe the prevalence and type of reproductive late effects male childhood cancer survivors
-
Identify risk factors of infertility and adverse pregnancy outcomes
-
Understand recommended screening for reproductive late effects
-
Appreciate options for fertility preservation
SUBSEQUENT NEOPLASMS AFTER CHILDHOOD CANCER
22 April 2022
20:00-21:30 (UTC +8 | Singapore Time)
07.00-08.30 (UTC -6 | Memphis Time)
Lucie Turcotte
University of Minnesota
Lecture #1: Subsequent Malignant Neoplasms Overview
​
By the end of the session, attendees will be able to:
-
Define the subsequent malignant neoplasms in childhood cancer survivors
-
Describe the onset of subsequent malignant neoplasm over the lifespan
-
Describe the burden of subsequent malignant neoplasms in survivors of childhood cancer
-
Identify risk factors for the development of common subsequent malignant neoplasms
Matthew Ehrhardt
St. Jude's Children Research Hospital
Lecture #2: Cancer Screening Guidelines After Childhood Cancer
​
By the end of the session, attendees will be able to:
-
Describe treatment-related risk factors for specific subsequent malignant neoplasms (breast, thyroid, colon, skin, hematologic)
-
Understand recommended screening for common subsequent malignant neoplasms
-
Understand differences between recommendations for high-risk cancer survivors and the general population cancer screening recommendations.
-
Describe recommended health behaviors for cancer prevention
NEUROLOGIC LATE EFFECTS AFTER CHILDHOOD CANCER
6 May 2022
20:00-21:30 (UTC +8 | Singapore Time)
07.00-08.30 (UTC -6 | Memphis Time)
Zsila Sadighi
The University of Texas MD Anderson Cancer Center
Lecture #1: Neurologic Late Effects After Childhood Cancer
​
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of neurologic late effects in childhood cancer survivors
-
Identify risk factors for neurologic late effects
-
Understand recommended screening for neurologic late effects
Daniel Bowers
University of Texas
Lecture #2: Stroke After Childhood Cancer
​
By the end of the session, attendees will be able to:
-
Describe the prevalence of stroke in childhood cancer survivors
-
Identify risk factors for stroke
-
Describe the impact of modifiable risk factors on risk of stroke
NEUROSESORY LATE EFFECTS AFTER CHILDHOOD CANCER
20 May 2022
20:00-21:30 (UTC +8 | Singapore Time)
07.00-08.30 (UTC -6 | Memphis Time)
Mary Ellen Hoehn
St. Jude's Children Research Hospital
Lecture #1: Ocular Late Effects After Childhood Cancer
​
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of ocular late effects in childhood cancer survivors
-
Identify risk factors for ocular late effects
-
Understand recommended screening for visual and ocular late effects
​​
Wendy Landier
University of Alabama
Lecture #2: Auditory Late Effects After Childhood Cancer
By the end of the session, attendees will be able to:
-
Describe the prevalence and type of auditory late effects in childhood cancer survivors
-
Identify risk factors for auditory late effects
-
Understand recommended screening for auditory late effects​
PSYCHOSOCIAL LATE EFFECTS OF CHILDHOOD CANCER PART 1
3 June 2022
20:00-21:30 (UTC +8 | Singapore Time)
07.00-08.30 (UTC -6 | Memphis Time)
Tara Brinkman
St. Jude's Children Research Hospital
Lecture #1: Functional and Social Outcomes After Childhood Cancer
By the end of the session, attendees will be able to:
-
Describe functional and social outcomes in childhood cancer survivors
-
Identify risk factors for deficits in social and functional outcomes
-
Understand recommended screening and interventions to optimize functional and social outcomes​
Kirsten Ness
St. Jude's Children Research Hospital
Lecture #2: Rehabilitation Across the Cancer Care Continuum
​
By the end of the session, attendees will be able to:
-
Identify targets for rehabilitation in childhood cancer patients and long-term survivors
-
Describe rehabilitation strategies and programs used in cancer patients and long-term survivors
-
Appreciate adaptations that may enhance success in rehabilitation
PSYCHOSOCIAL LATE EFFECTS OF CHILDHOOD CANCER PART 2
17 June 2022
20:00-21:30 (UTC +8 | Singapore Time)
07.00-08.30 (UTC -6 | Memphis Time)
Jordan Gilleland Marchak
Emory University School of Medicine
Lecture #1: Mental Health After Childhood Cancer
​
By the end of the session, attendees will be able to:
-
Describe mental health outcomes in childhood cancer survivors
-
Identify risk factors for mental health impairment
-
Understand recommended screening for mental health impairment
-
Describe interventions to support mental health in survivors of childhood cancer
Rachel Tillery Webster
St. Jude's Children Research Hospital
Lecture #2: The Effect of Childhood Cancer on Families and Siblings
​
By the end of the session, attendees will be able to:
-
Describe perspectives of siblings and families affected by childhood cancer
-
Understand how childhood cancer affects long term health and functioning of families and siblings
-
Appreciate resources to support families and siblings affected by childhood cancer